Pneumagen
Phase 2Breathing new life into at-risk patients by transforming the prevention and treatment of viral respiratory infections
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $22.5M
About
Breathing new life into at-risk patients by transforming the prevention and treatment of viral respiratory infections
Biologics
Funding History
3Total raised:$22.5M
Series B$12MJul 15, 2022
Series A$8MSep 15, 2020
Seed$2.5MJun 15, 2018